HCV communication within ego-centric networks of men and women who inject drugs.

[1]  F. Hutton,et al.  Women Who Inject Drugs (WWID): Stigma, Gender and Barriers to Needle Exchange Programmes (NEPs) , 2021, Contemporary Drug Problems.

[2]  D. Holtzman,et al.  The Changing Epidemiology of Hepatitis C Virus Infection in the United States During the Years 2010 to 2018. , 2021, American journal of public health.

[3]  Q. Ali,et al.  ROLE OF MODERN TECHNOLOGY FOR TREATMENT OF HCV , 2020, Biological and Clinical Sciences Research Journal.

[4]  O. Laeyendecker,et al.  Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore , 2020, BMC Infectious Diseases.

[5]  Brandon D. L. Marshall,et al.  “Health Is on the Back Burner:” Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs , 2020, Journal of General Internal Medicine.

[6]  S. Bellamy,et al.  Motivations for PrEP-Related Interpersonal Communication Among Women Who Inject Drugs: A Qualitative Egocentric Network Study , 2020, Qualitative health research.

[7]  O. Falade-Nwulia,et al.  Hepatitis C treatment uptake among people who inject drugs in the oral direct‐acting antiviral era , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[8]  L. Smith,et al.  Preventing transitions into injection drug use: A call for gender-responsive upstream prevention. , 2020, The International journal on drug policy.

[9]  C. Latkin,et al.  Network‐based recruitment of people who inject drugs for hepatitis C testing and linkage to care , 2020, Journal of viral hepatitis.

[10]  Alexandria Macmadu,et al.  Barriers to Healthcare for People Who Inject Drugs: A Survey at a Syringe Exchange Program , 2020, Substance use & misuse.

[11]  S. Shiboski,et al.  HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco , 2019, PloS one.

[12]  E. Trejos-Castillo,et al.  Gender Differences in Risky Injection Practices Among People Who Inject Drugs in Colombia , 2019, Addictive Disorders & Their Treatment.

[13]  E. Rice,et al.  Individual and Social Network Correlates of Sexual Health Communication Among Youth Experiencing Homelessness , 2019, AIDS and Behavior.

[14]  B. Marshall,et al.  Elimination of HIV transmission through novel and established prevention strategies among people who inject drugs. , 2019, The lancet. HIV.

[15]  C. Fisher,et al.  Establishing trust in HIV/HCV research among people who inject drugs (PWID): Insights from empirical research , 2018, PloS one.

[16]  G. Dore,et al.  Understanding facilitators and barriers of direct‐acting antiviral therapy for hepatitis C virus infection in prison , 2018, Journal of viral hepatitis.

[17]  K. Buchacz,et al.  Notes from the Field: HIV Infection Investigation in a Rural Area — West Virginia, 2017 , 2018, MMWR. Morbidity and mortality weekly report.

[18]  D. Holtzman,et al.  Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014 , 2018, American journal of public health.

[19]  K. Mergenhagen,et al.  The Effect of Psychosocial Factors on Success Rates of Hepatitis C Treatment. , 2017, Psychosomatics.

[20]  J. Rockstroh,et al.  Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there? , 2017, Journal of the International AIDS Society.

[21]  O. Weiland,et al.  Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program , 2017, Infectious diseases.

[22]  G. Dore,et al.  Treatment of HCV in persons who inject drugs: Treatment as prevention , 2017, Clinical liver disease.

[23]  D. Nelson,et al.  Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review. , 2017, Annals of internal medicine.

[24]  A. Mirzazadeh,et al.  Higher incidence of HCV in females compared to males who inject drugs: A systematic review and meta‐analysis , 2017, Journal of viral hepatitis.

[25]  G. Foster,et al.  Second generation direct-acting antivirals - Do we expect major improvements? , 2016, Journal of hepatology.

[26]  J. Pawlotsky.  Hepatitis C Drugs: Is Next Generation the Last Generation? , 2016, Gastroenterology.

[27]  K. Page,et al.  HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and Treatment , 2015, Journal of acquired immune deficiency syndromes.

[28]  K. Malinowska-Sempruch.  What Interventions Are Needed for Women and Girls Who Use Drugs? A Global Perspective , 2015, Journal of acquired immune deficiency syndromes.

[29]  P. Peters,et al.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone — Indiana, 2015 , 2015, MMWR. Morbidity and mortality weekly report.

[30]  R. Garfein,et al.  Awareness of HCV infection among persons who inject drugs in San Diego, California. , 2015, American journal of public health.

[31]  S. Strathdee,et al.  Women, drugs and HIV. , 2015, The International journal on drug policy.

[32]  N. El-Bassel,et al.  Systematic Review of Couple-Based HIV Intervention and Prevention Studies: Advantages, Gaps, and Future Directions , 2014, AIDS and Behavior.

[33]  S. Strathdee,et al.  Drug use as a driver of HIV risks: re-emerging and emerging issues , 2014, Current opinion in HIV and AIDS.

[34]  S. Strathdee,et al.  People Who Inject Drugs in Intimate Relationships: It Takes Two to Combat HIV , 2014, Current HIV/AIDS Reports.

[35]  Bryce D. Smith,et al.  "To share or not to share?" Serosorting by hepatitis C status in the sharing of drug injection equipment among NHBS-IDU2 participants. , 2013, The Journal of infectious diseases.

[36]  Bryce D. Smith,et al.  Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. , 2013, World journal of gastroenterology.

[37]  G. Dore,et al.  Epidemiology and natural history of HCV infection , 2013, Nature Reviews Gastroenterology &Hepatology.

[38]  C. Treloar,et al.  Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  N. Bath,et al.  Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  C. Latkin,et al.  "Drinking buddies" and alcohol dependence symptoms among African American men and women in Baltimore, MD. , 2013, Drug and alcohol dependence.

[41]  D. D. Des Jarlais,et al.  Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. , 2012, Drug and alcohol dependence.

[42]  B. Cowie,et al.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.

[43]  J. Lambert,et al.  Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration. , 2010, AIDS patient care and STDs.

[44]  H. Hagan,et al.  Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users. , 2009, Drug and alcohol dependence.

[45]  J. Louw,et al.  Stigma, treatment beliefs, and substance abuse treatment use in historically disadvantaged communities. , 2009, African journal of psychiatry.

[46]  D. D. Des Jarlais,et al.  Barriers and Facilitators to Undergoing Hepatitis C Virus (HCV) Testing through Drug Treatment Programs , 2008 .

[47]  Cecilia Menjívar,et al.  Talking about the "Epidemic of the Millennium": Religion, Informal Communication, and HIV/AIDS in Sub-Saharan Africa , 2008 .

[48]  A. Nyamathi,et al.  Attitudes of homeless and drug-using youth regarding barriers and facilitators in delivery of quality and culturally sensitive health care. , 2008, Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc.

[49]  J. Neale,et al.  Barriers to accessing generic health and social care services: a qualitative study of injecting drug users. , 2007, Health & social care in the community.

[50]  C. Latkin,et al.  Gender Differences in Social Network Influence among Injection Drug Users: Perceived Norms and Needle Sharing , 2007, Journal of Urban Health.

[51]  L. Bogart,et al.  Condom Attitudes and Behaviors Among Injection Drug Users Participating in California Syringe Exchange Programs , 2005, AIDS and Behavior.

[52]  Colin W Shepard,et al.  Global epidemiology of hepatitis C virus infection. , 2005, The Lancet. Infectious diseases.

[53]  J. Inciardi,et al.  Barriers to Health and Social Services for Street-Based Sex Workers , 2005, Journal of health care for the poor and underserved.

[54]  L. Gramling,et al.  Stigma: a health barrier for women with HIV/AIDS. , 2004, The Journal of the Association of Nurses in AIDS Care : JANAC.

[55]  Victor Agadjanian.  Men's Talk About “Women's Matters” , 2002 .

[56]  M. McPherson,et al.  Birds of a Feather: Homophily in Social Networks , 2001 .

[57]  N. Lin,et al.  Social support, stressful life events, and illness: a model and an empirical test. , 1979, Journal of health and social behavior.

[58]  Notes from the field: risk factors for hepatitis C virus infections among young adults--Massachusetts, 2010. , 2011, MMWR. Morbidity and mortality weekly report.